Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: HTC Appeal Pacer..

So (ronran, geoff, biajj, others),

Would it be safe to say that we are, for all intents and purposes, at square one again concerning a court-determined win for the validity of the MMP?

If this "de novo" approach involves a whole review of the claims constructions, doesn't this mean we are starting over again?

Also, since the ITC ruling will now be allowed into the appeal review, how does this weigh against us?

Add the bankrupcty entanglement with TPL, and we are looking at three negatives ahead of us.

How will we be able to convince companies to "sign on the dotted line" for hefty licensing of the MMP given all of this?

Can anyone offer a positive thought for this mess we have before us?

Share
New Message
Please login to post a reply